The use of the carbonic anhydrase XII (CAXII) inhibitor, Ad-DKK3, fasudil, and MRS1220 reduced the expression of ABCB1, ABCG2, and ABCC1 in GBM-xenografted mice, respectively [31,35,42]. This evidence concerns the gene ABCC1 and glioblastoma.